Guangli Liu Selected Research

3,5-dicaffeoylquinic acid

2/2021	PK-PD Correlation of Erigeron Breviscapus Injection in the Treatment of Cerebral Ischemia-Reperfusion Injury Model Rats.
1/2021	Protective mechanism of Erigeron breviscapus injection on blood-brain barrier injury induced by cerebral ischemia in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guangli Liu Research Topics

Disease

2	Brain Ischemia (Cerebral Ischemia) 02/2021 - 01/2021
1	Stomach Neoplasms (Stomach Cancer) 06/2022
1	Cerebral Infarction 02/2021
1	Ischemic Stroke 02/2021
1	Reperfusion Injury 01/2021
1	Stroke (Strokes) 01/2021
1	Colonic Neoplasms (Colon Cancer) 01/2021
1	Wounds and Injuries (Trauma) 01/2021
1	Hyperemia 09/2018

Drug/Important Bio-Agent (IBA)

2	3,5-dicaffeoylquinic acidIBA 02/2021 - 01/2021
2	Therapeutic UsesIBA 02/2021 - 01/2021
2	scutellarinIBA 02/2021 - 01/2021
1	Fibrinogen (Factor I)FDA Link 06/2022
1	Sincalide FDA Link 06/2022
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 06/2022
1	Chlorogenic AcidIBA 02/2021
1	Pharmaceutical PreparationsIBA 02/2021
1	salicylhydroxamic acid (SHAM)IBA 02/2021
1	3,4-di-O-caffeoylquinic acidIBA 02/2021
1	AcidsIBA 02/2021
1	Evans Blue (Blue, Evans)FDA Link 01/2021
1	Matrix Metalloproteinases (MMPs)IBA 01/2021
1	Oxygen (Dioxygen)IBA 09/2018

Therapy/Procedure

1	Immunotherapy 01/2021
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2021
1	Drug Therapy (Chemotherapy) 01/2021